Matthew K. Loughran

Matthew is a Health Policy Analyst in our Life Sciences Health Industry Group. Drawing on nearly a decade of experience at Bloomberg Law – where he served as the Practice Lead for their Health Care Group – along with a background as a practicing lawyer and law clerk, Matt monitors federal and state policy developments coming out of CMS, OIG, HHS, FDA and other federal and state agencies.

Credentials

Education

Rutgers School of Law, 2009, J.D.
St. John's College, 2001, M.A., Liberal Arts
University of Notre Dame, 1998, B.A., Government and International Relations

Professional affiliations

American Health Lawyers Association
D.C. Bar (Member of Health Law; Corporate Finance & Securities Law; and Administrative & Agency Practice Communities)

Clerkships

State Superior Court - New Jersey, Appellate Division, Honorable Jack M. Sabatino

Practices

Emerging Technologies

Digital Health & Artificial Intelligence

Industries

Health Care & Life Sciences

Health Care Services Regulatory, Compliance & Operations Counseling

Health Care & Life Sciences Transactions

Life Sciences Manufacturer Regulatory, Compliance & Operations Counseling

Insights

Corporate Compliance Insights

The DOJ Wants Strong FCA Whistleblower Lawsuits From Data Miners

14 May 2026

Insights

Reed Smith In-depth

Unilateral declaration by the Secretary sets an independent standard for the practice of medicine

30 December 2025

Insights

Reed Smith In-depth

Final 2025 CMS Physician Fee Schedule Rule includes changes to Medicare overpayment standard

2 December 2024

Insights

Reed Smith In-depth

Unilateral declaration by the Secretary sets an independent standard for the practice of medicine

30 December 2025

Insights

Reed Smith In-depth

Final 2025 CMS Physician Fee Schedule Rule includes changes to Medicare overpayment standard

2 December 2024

1 / 2

View all

Blogs

1 / 20

ONC Finalizes HTI-5, De-regulating Less than Anticipated and Punting on Information Blocking Changes
(30 October 2026)
New coordination of voluntary self-disclosure policies announced in criminal health care fraud matters
(23 October 2026)
Delegation of permissive Medicare and Medicaid exclusion authority raises questions and may further politicize fraud enforcement
(15 October 2026)
New California Laws Regulate AI Use in Health Care
(8 October 2026)
Two Fronts, One Strategy: Louisiana, Arkansas, and Alabama Take Aim at Mail-Order Mifepristone Providers and State Shield Laws
(2 October 2026)
CMS Releases GLOBE Rule with “Most Favored Nation” Pricing
(1 October 2026)
Industry Input Sought on Reasonable and Relevant Pharmacy Contract Terms
(24 September 2026)
Justice Manual Updates Provide More Ammunition to Defend Against FCA Actions
(21 September 2026)
Your Regulators Are Talking: FDA and SEC Enter into Three-Year Agreement to Share Nonpublic Information
(3 September 2026)
Eleventh Circuit Rules Qui Tam Provision of the False Claims Act Does Not Violate Appointments Clause
(2 September 2026)
Illinois Makes Health Care Transaction Notice Law Permanent, Expands Private Equity Coverage
(19 August 2026)
DOJ’s National Fraud Enforcement Division Announces Priorities
(14 August 2026)
New IDR Operations Rule Offers Meaningful Improvements for Physicians, But Concerns Remain
(12 June 2026)
CMS adds Moratoria to new Hospice and Home Health Provider Enrollments
(27 May 2026)
Supreme Court Reinstates Availability of Mifepristone without In-Person Appointment
(16 May 2026)
Fifth Circuit Stay Reinstates Nationwide In-Person Dispensing Requirement for Mifepristone
(4 May 2026)
DOJ Announces FCA Initiative for Data Miners
(1 May 2026)
CMS makes structural changes to Star Ratings system for Medicare Advantage and Part D plans
(15 April 2026)
New No Surprises FAQ Bad News for Physicians using IDR process
(13 April 2026)
The Rise and Withdrawal of the Requestor Preferences Exception under the Information Blocking Rule: Implications for Radiology Providers and Test Result Embargoes
(12 March 2026)

View all

Events

Health Ethics Trust Compliance Program Assessors Course

Thursday, February 19, 2026

1 / 4

Our people

Our leadership

Our practice

Our insights

EU Product Liability Directive: Where things stand with Member State transposition

Our commitments

Join us

Our commitments

Matthew K. Loughran

Washington, D.C.

Credentials

Education

Professional affiliations

Clerkships

Insights

The DOJ Wants Strong FCA Whistleblower Lawsuits From Data Miners

Unilateral declaration by the Secretary sets an independent standard for the practice of medicine

Final 2025 CMS Physician Fee Schedule Rule includes changes to Medicare overpayment standard

Unilateral declaration by the Secretary sets an independent standard for the practice of medicine

Final 2025 CMS Physician Fee Schedule Rule includes changes to Medicare overpayment standard

Blogs

ONC Finalizes HTI-5, De-regulating Less than Anticipated and Punting on Information Blocking Changes

New coordination of voluntary self-disclosure policies announced in criminal health care fraud matters

Delegation of permissive Medicare and Medicaid exclusion authority raises questions and may further politicize fraud enforcement

New California Laws Regulate AI Use in Health Care

Two Fronts, One Strategy: Louisiana, Arkansas, and Alabama Take Aim at Mail-Order Mifepristone Providers and State Shield Laws

CMS Releases GLOBE Rule with “Most Favored Nation” Pricing

Industry Input Sought on Reasonable and Relevant Pharmacy Contract Terms

Justice Manual Updates Provide More Ammunition to Defend Against FCA Actions

Your Regulators Are Talking: FDA and SEC Enter into Three-Year Agreement to Share Nonpublic Information

Eleventh Circuit Rules Qui Tam Provision of the False Claims Act Does Not Violate Appointments Clause

Illinois Makes Health Care Transaction Notice Law Permanent, Expands Private Equity Coverage

DOJ’s National Fraud Enforcement Division Announces Priorities

New IDR Operations Rule Offers Meaningful Improvements for Physicians, But Concerns Remain

CMS adds Moratoria to new Hospice and Home Health Provider Enrollments

Supreme Court Reinstates Availability of Mifepristone without In-Person Appointment

Fifth Circuit Stay Reinstates Nationwide In-Person Dispensing Requirement for Mifepristone

DOJ Announces FCA Initiative for Data Miners

CMS makes structural changes to Star Ratings system for Medicare Advantage and Part D plans

New No Surprises FAQ Bad News for Physicians using IDR process

The Rise and Withdrawal of the Requestor Preferences Exception under the Information Blocking Rule: Implications for Radiology Providers and Test Result Embargoes

Events

Health Care Legislation, Regulation, and Investigations after the Midterms

Health care week returns March 16-19: Virtual CLE series

Health Ethics Trust Compliance Program Assessors Course

11th Annual Health Care Conference